“Synthesis Molecular Docking and Biological Evaluation of new 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenylureas as Potent Type II VEGFR-2 Tyrosine Kinase Inhibitors” Conference CHEMMEDCHEM

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusPublished - 2014

Cite this